BRPI1012931A2 - soluções para infusão e injeção de diacetato de ipamorelina - Google Patents

soluções para infusão e injeção de diacetato de ipamorelina

Info

Publication number
BRPI1012931A2
BRPI1012931A2 BRPI1012931A BRPI1012931A BRPI1012931A2 BR PI1012931 A2 BRPI1012931 A2 BR PI1012931A2 BR PI1012931 A BRPI1012931 A BR PI1012931A BR PI1012931 A BRPI1012931 A BR PI1012931A BR PI1012931 A2 BRPI1012931 A2 BR PI1012931A2
Authority
BR
Brazil
Prior art keywords
infusion
injection solutions
ipamorelin diacetate
ipamorelin
diacetate
Prior art date
Application number
BRPI1012931A
Other languages
English (en)
Inventor
Beidler Daniel
Weibel Helle
Braglia Riccardo
Garcia Rubio Silvina
Original Assignee
Helsinn Therapeutics Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42272260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1012931(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Helsinn Therapeutics Us Inc filed Critical Helsinn Therapeutics Us Inc
Publication of BRPI1012931A2 publication Critical patent/BRPI1012931A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
BRPI1012931A 2009-06-12 2010-05-27 soluções para infusão e injeção de diacetato de ipamorelina BRPI1012931A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18659509P 2009-06-12 2009-06-12
PCT/US2010/036365 WO2010144265A2 (en) 2009-06-12 2010-05-27 Ipamorelin diacetate injection and infusion solutions

Publications (1)

Publication Number Publication Date
BRPI1012931A2 true BRPI1012931A2 (pt) 2018-01-30

Family

ID=42272260

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1012931A BRPI1012931A2 (pt) 2009-06-12 2010-05-27 soluções para infusão e injeção de diacetato de ipamorelina

Country Status (24)

Country Link
US (1) US20100317581A1 (pt)
EP (1) EP2440180B1 (pt)
JP (1) JP2012529510A (pt)
KR (1) KR20120030530A (pt)
CN (1) CN102481251A (pt)
AU (1) AU2010259102B2 (pt)
BR (1) BRPI1012931A2 (pt)
CA (1) CA2765233A1 (pt)
CL (1) CL2011003131A1 (pt)
CO (1) CO6470880A2 (pt)
CR (1) CR20110618A (pt)
CU (1) CU20110232A7 (pt)
DO (1) DOP2011000383A (pt)
EA (1) EA201270011A1 (pt)
EC (1) ECSP11011516A (pt)
GT (1) GT201100318A (pt)
MX (1) MX2011013113A (pt)
NI (1) NI201100212A (pt)
NZ (1) NZ596641A (pt)
PE (1) PE20121064A1 (pt)
SG (1) SG176717A1 (pt)
TW (1) TW201106961A (pt)
UA (1) UA104762C2 (pt)
WO (1) WO2010144265A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6193017B2 (ja) * 2013-06-28 2017-09-06 テルモ株式会社 生体血管内血液置換用液体、生体血管内血液置換用液体製剤およびプレフィルドシリンジ
JP6562902B2 (ja) 2014-03-28 2019-08-21 テルモ株式会社 生体血管内血液置換用液体、生体血管内血液置換用液体製剤およびプレフィルドシリンジ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2179597A1 (en) * 1993-12-23 1995-06-29 Nils Langeland Johansen Compounds with growth hormone releasing properties
EP1200111A1 (en) * 1999-06-04 2002-05-02 Novo Nordisk A/S Compositions for the treatment of the catabolic state of prolonged critical illness
JP4874989B2 (ja) * 2004-11-22 2012-02-15 ノヴォ ノルディスク アー/エス 可溶性で安定なインスリン含有調合物
KR100700869B1 (ko) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
EP2129401B8 (en) * 2006-12-21 2020-01-15 Amgen Inc. Stable buffered formulations containing polypeptides
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
CN101951937A (zh) * 2007-12-21 2011-01-19 赫尔辛医疗股份公司 使用伊帕瑞林刺激胃肠系统动力的方法
UA105657C2 (uk) * 2009-02-27 2014-06-10 Хелсінн Терапьютікс (Ю.Ес.), Інк. Поліпшені способи лікування мігрені на основі анамореліну

Also Published As

Publication number Publication date
CR20110618A (es) 2012-03-02
AU2010259102A1 (en) 2012-01-12
ECSP11011516A (es) 2012-03-30
NZ596641A (en) 2013-12-20
CA2765233A1 (en) 2010-12-16
EP2440180B1 (en) 2014-08-27
TW201106961A (en) 2011-03-01
EP2440180A2 (en) 2012-04-18
CO6470880A2 (es) 2012-06-29
US20100317581A1 (en) 2010-12-16
PE20121064A1 (es) 2012-09-03
GT201100318A (es) 2014-10-13
AU2010259102B2 (en) 2013-09-12
CL2011003131A1 (es) 2012-08-17
MX2011013113A (es) 2012-02-21
DOP2011000383A (es) 2012-05-31
CU20110232A7 (es) 2012-06-21
JP2012529510A (ja) 2012-11-22
KR20120030530A (ko) 2012-03-28
UA104762C2 (ru) 2014-03-11
SG176717A1 (en) 2012-01-30
CN102481251A (zh) 2012-05-30
EA201270011A1 (ru) 2012-05-30
WO2010144265A3 (en) 2011-11-24
WO2010144265A2 (en) 2010-12-16
NI201100212A (es) 2012-04-11

Similar Documents

Publication Publication Date Title
NO2024044I1 (no) Insulin icodec
NO2017031I1 (no) insulin aspart
BRPI0908416A2 (pt) Seringa para injeção
DK3184136T3 (da) Injektor
DK2544738T3 (da) Injektionsanordning
DK2512551T3 (da) Selvinjektionsapparat
DK3011989T3 (da) Injektionsanordning
EP3865162C0 (en) RINSE SYRINGE ASSEMBLY
BRPI1014404A2 (pt) cânula dotada de recurso de cânula e recurso de encaixe em sobreposição
EP2618867A4 (en) Infusion pumps
SG11201504909SA (en) Adhesive assemblies and microneedle injection apparatuses comprising same
BR112013009593A2 (pt) mecanismos de bombas e métodos de fabricação
PL2403520T3 (pl) Preparaty insuliny do szybkiego wychwytu
DK2538996T3 (da) Autoinjektor med nålehylster og nålebeskyttelseshætte
BR112012004393A2 (pt) montagem de agulha de injeção e dispoisitvo de injeção de fármaco.
DK2962770T3 (da) Medicinsk multi-fluidinjektionssystem
DK2451508T3 (da) Frostbeskyttet injektionsanordning
EP2667915A4 (en) INJEKTOR
EP2545950A4 (en) Injection needle assembly and drug injection device
EP2543405A4 (en) SYRINGE
EP2484393A4 (en) PRE-FILLED SYRINGE
EP3391921C0 (en) BALLISTIC MICRO-NEEDLE INFUSION DEVICE
HUE054113T2 (hu) Injekciós készülék gyógyszerbejuttatáshoz
EP3597242C0 (en) NEEDLELESS INJECTION DEVICE
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]